What Does Hikma Pharmaceuticals Do?

Total employees9670
HeadquartersLondon
Founded1978

Hikma Pharmaceuticals PLC is a multinational pharmaceutical company dedicated to improving health by developing, manufacturing, and marketing a broad range of high-quality, affordable medicines. With a primary focus on the Middle East and North Africa (MENA), the United States, and Europe, Hikma's portfolio includes injectables, generics, and branded pharmaceuticals across various therapeutic areas. The company strives to make essential medicines more accessible to patients worldwide, emphasizing quality, safety, and innovation in its operations.

Where Is Hikma Pharmaceuticals's Headquarters?

HQ Function

Serves as the central hub for global strategy, corporate governance, finance, investor relations, and overarching management of Hikma's worldwide operations.

Notable Features:

Located in Mayfair, a prestigious London district, suggesting a focus on global business and finance. The office itself is likely a modern, professional space within a commercial building, designed for corporate functions.

Work Culture:

Likely professional, results-oriented, with an emphasis on global collaboration, ethical practices, and innovation in pharmaceuticals. Corporate functions would foster strategic thinking, international coordination, and adherence to high standards of governance.

HQ Significance:

Central point for strategic decision-making, financial oversight, and investor communications that guide Hikma's global operations, market expansion, and partnerships. Its London location provides access to international finance, talent, and a key regulatory environment.

Values Reflected in HQ: The Mayfair location and nature of a corporate HQ reflect professionalism, global ambition, strategic importance, and a commitment to robust governance and financial stewardship, aligning with Hikma's mission to be a leading global pharmaceutical company.

Location:

Hikma Pharmaceuticals maintains a significant global presence with functions supported worldwide. This includes research and development (R&D) for new drug formulations and generics; state-of-the-art manufacturing facilities for injectables, oral solids, and other dosage forms in the US, Europe, and MENA; comprehensive quality assurance and control systems; regulatory affairs teams managing submissions across numerous international bodies; a robust global supply chain and logistics network; and tailored sales and marketing operations addressing the diverse needs of markets in the United States, Europe, and the Middle East & North Africa (MENA) region.

Street Address:

13 Hanover Square

City:

London

State/Province:

N/A

Country:

United Kingdom

Where Else Does Hikma Pharmaceuticals Operate Around the World?

Berkeley Heights, New Jersey, USA

Address: 200 Connell Drive, Suite 5000, Berkeley Heights, NJ 07922, USA

To effectively navigate and lead Hikma's presence in the complex US pharmaceutical market, ensuring compliance with FDA regulations, and driving growth strategies tailored to American healthcare needs and demands.

Amman, Jordan

Address: P.O. Box 182400, Amman 11118, Jordan (Bayader Wadi El-Seer)

Serves as a foundational site for Hikma's operations in the MENA region, leveraging local expertise and infrastructure to supply essential medicines and drive growth in these markets.

Buying Intent Signals for Hikma Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Hikma Pharmaceuticals? Meet the Executive Team

As of April 2025, Hikma Pharmaceuticals' leadership includes:

Riad Mishlawi - Chief Executive Officer
Khalid Nabilsi - Chief Financial Officer
Mazen Darwazah - Executive Vice Chairman and President of MENA
Dr. Bill Larkins - President, Injectables
Brian Hoffmann - President, Generics
Manel F. Terraza - Group General Counsel & Company Secretary
Dr. Hoda Ezzat - President, Branded

Who's Investing in Hikma Pharmaceuticals?

Hikma Pharmaceuticals has been backed by several prominent investors over the years, including:

Darhold Ltd. (Entities associated with the Darwazah family)
BlackRock, Inc.
The Vanguard Group, Inc.
Norges Bank Investment Management
FIL Investment Advisers (UK) Ltd.

What Leadership Changes Has Hikma Pharmaceuticals Seen Recently?

Hire2
Exits1

Over the past 12-18 months, Hikma Pharmaceuticals has seen significant leadership transitions, including the appointment of a new CEO through internal promotion, the confirmation of its CFO, and the departure of the previous CEO. These changes reflect a strategic evolution at the top of the company.

Departures

Siggi Olafsson, Siggi Olafsson departed from his role as CEO after a transition period.

New Appointments:

Riad Mishlawi, Riad Mishlawi assumed the role of Chief Executive Officer, promoted from President of Injectables.
Khalid Nabilsi, Khalid Nabilsi was appointed as permanent Chief Financial Officer, having served as Interim CFO.

What Technology (Tech Stack) Is Used byHikma Pharmaceuticals?

Discover the tools Hikma Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Hikma Pharmaceuticals Email Formats and Examples

Hikma Pharmaceuticals commonly uses a standardized email format for its employees globally. The most prevalent pattern appears to be the first initial followed by the last name.

[first_initial][last]@hikma.com

Format

jsmith@hikma.com

Example

85%

Success rate

What's the Latest News About Hikma Pharmaceuticals?

Hikma Pharmaceuticals PLCMarch 7, 2024

Hikma Pharmaceuticals reports strong 2023 full year results

Hikma announced robust financial results for the full year 2023, demonstrating significant revenue growth and strong profitability. The performance was driven by excellent results in its Injectables and Branded businesses, alongside a solid contribution from Generics....more

Hikma Pharmaceuticals PLCFebruary 20, 2024

Hikma Pharmaceuticals launches Phenylephrine Hydrochloride Injection, USP in the US

Hikma announced the launch of Phenylephrine Hydrochloride Injection, USP, 10mg/mL, through its US affiliate. This launch expands their growing portfolio of essential injectable medicines for the US market, reinforcing their commitment to supplying critical hospital products....more

Hikma Pharmaceuticals PLCNovember 9, 2023

Hikma Pharmaceuticals Trading Update - November 2023

Hikma provided a positive trading update, highlighting strong performance across its three core businesses and raising its full-year guidance for 2023. The update reflected continued operational momentum and successful strategic execution....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Hikma Pharmaceuticals, are just a search away.